X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (9485) 9485
humans (9396) 9396
uterine cervical neoplasms - metabolism (4706) 4706
uterine cervical neoplasms - pathology (4511) 4511
cervical cancer (3347) 3347
oncology (3220) 3220
middle aged (2866) 2866
adult (2788) 2788
cancer (2287) 2287
uterine cervical neoplasms - genetics (2251) 2251
aged (1802) 1802
immunohistochemistry (1683) 1683
hela cells (1561) 1561
cell line, tumor (1551) 1551
animals (1545) 1545
uterine cervical neoplasms - virology (1541) 1541
expression (1515) 1515
apoptosis (1371) 1371
carcinoma, squamous cell - metabolism (1231) 1231
prognosis (1187) 1187
uterine cervical neoplasms - drug therapy (1173) 1173
carcinoma (1160) 1160
obstetrics & gynecology (1123) 1123
carcinoma, squamous cell - pathology (1070) 1070
mice (1069) 1069
pathology (1067) 1067
human papillomavirus (1058) 1058
gene expression regulation, neoplastic (1033) 1033
cell biology (854) 854
tumors (850) 850
uterine cervical neoplasms - diagnosis (819) 819
biomarkers, tumor - metabolism (787) 787
uterine cervix (775) 775
neoplasm staging (772) 772
biochemistry & molecular biology (767) 767
cervical intraepithelial neoplasia - metabolism (755) 755
cervical intraepithelial neoplasia - pathology (746) 746
gene expression (746) 746
analysis (735) 735
cervix (730) 730
research (726) 726
proteins (725) 725
apoptosis - drug effects (683) 683
cell proliferation (680) 680
tumor cells, cultured (680) 680
cervix uteri - metabolism (660) 660
papillomavirus infections (646) 646
metastasis (616) 616
uterine cervical neoplasms - enzymology (609) 609
papillomavirus infections - virology (600) 600
adenocarcinoma - metabolism (586) 586
cells (584) 584
health aspects (578) 578
cervix uteri - pathology (569) 569
human-papillomavirus (568) 568
neoplasm invasiveness (541) 541
male (538) 538
papillomaviridae - genetics (528) 528
genetic aspects (522) 522
aged, 80 and over (519) 519
risk factors (502) 502
cervical intraepithelial neoplasia - virology (488) 488
oncogene proteins, viral - genetics (486) 486
uterine cervical neoplasms - immunology (482) 482
uterine cervical neoplasms - radiotherapy (482) 482
papillomavirus infections - metabolism (479) 479
carcinoma, squamous cell - genetics (477) 477
care and treatment (474) 474
cell proliferation - drug effects (470) 470
oncogene proteins, viral - metabolism (469) 469
research article (469) 469
development and progression (464) 464
breast-cancer (462) 462
activation (460) 460
antineoplastic agents - pharmacology (459) 459
adenocarcinoma - pathology (458) 458
proliferation (453) 453
down-regulation (450) 450
squamous-cell carcinoma (449) 449
uterine cervical neoplasms - therapy (448) 448
chemotherapy (442) 442
mice, nude (440) 440
p53 (440) 440
reverse transcriptase polymerase chain reaction (438) 438
disease progression (436) 436
growth (436) 436
rna, messenger - metabolism (435) 435
hpv (429) 429
signal transduction (428) 428
blotting, western (427) 427
cell cycle (427) 427
polymerase chain reaction (427) 427
medicine, research & experimental (425) 425
transfection (424) 424
tumor suppressor protein p53 - metabolism (415) 415
rna, messenger - genetics (414) 414
protein (413) 413
women (407) 407
young adult (400) 400
up-regulation (391) 391
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9124) 9124
Chinese (341) 341
Japanese (146) 146
Russian (106) 106
German (87) 87
Polish (33) 33
French (26) 26
Italian (23) 23
Spanish (15) 15
Bulgarian (3) 3
Czech (3) 3
Portuguese (3) 3
Serbian (3) 3
Dutch (2) 2
Korean (2) 2
Romanian (2) 2
Afrikaans (1) 1
Croatian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: a cancer journal for clinicians, ISSN 0007-9235, 2016, Volume 66, Issue 5, pp. 408 - 436
... has been the recognition that uterine cervical cancer could be prevented by population‐based screening for precursor lesions. As such, every physician hopes for the day... 
carcinoma in situ | dysplasia | intraepithelial neoplasia | preinvasive neoplasia | precancer | HIGH-GRADE DYSPLASIA | URINARY-BLADDER | BARRETTS-ESOPHAGUS | HUMAN-PAPILLOMAVIRUS | INTRADUCTAL CARCINOMA | CARCINOMA IN-SITU | PAPILLARY UROTHELIAL HYPERPLASIA | ONCOLOGY | SINGLE ACADEMIC CENTER | TERM-FOLLOW-UP | NECK-CANCER IMPLICATIONS | Humans | Lung Neoplasms - metabolism | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Uterine Cervical Neoplasms - pathology | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Esophageal Neoplasms - pathology | Breast Neoplasms - therapy | American Cancer Society | Uterine Cervical Neoplasms - metabolism | Skin Neoplasms - diagnosis | Urinary Bladder Neoplasms - pathology | Female | Ovarian Neoplasms - metabolism | Uterine Cervical Neoplasms - therapy | Skin Neoplasms - pathology | Prostatic Neoplasms - pathology | Uterine Cervical Neoplasms - diagnosis | Skin Neoplasms - therapy | Carcinoma in Situ - pathology | Ovarian Neoplasms - diagnosis | Pancreatic Neoplasms - pathology | Risk Factors | Head and Neck Neoplasms - therapy | Lung Neoplasms - therapy | Carcinoma in Situ - therapy | Head and Neck Neoplasms - pathology | Skin Neoplasms - metabolism | Breast Neoplasms - pathology | Ovarian Neoplasms - therapy | Head and Neck Neoplasms - diagnosis | Breast Neoplasms - diagnosis | Carcinoma in Situ - diagnosis | Carcinoma in Situ - metabolism | Lung Neoplasms - diagnosis | Population Surveillance | Prevention | Care and treatment | Gastrointestinal system | Practice | Pathologists | Metastasis | Patients | Health aspects | Cervical cancer | Risk factors | Pathology | Usage | Diagnosis | Tumors | Medical diagnosis | Cancer
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 4, pp. e95043 - e95043
Journal Article
Cancer letters, ISSN 0304-3835, 2007, Volume 251, Issue 1, pp. 132 - 145
.... Therefore, we tested the in vitro sensitivity of broad cell line panels derived from lung, colorectal, breast, prostate and cervical cancer, which are the prevalent cancer types characterized... 
Hematology, Oncology and Palliative Medicine | Chemotherapy | Lung cancer | Betulinic acid | Colorectal cancer | Breast cancer | Prostate cancer | Cervical cancer | Apoptosis | ACTIVATION | colorectal cancer | INDUCED APOPTOSIS | breast cancer | apoptosis | TUMOR-CELLS | betulinic acid | IDENTIFICATION | cervical cancer | chemotherapy | CYTOTOXIC ACTIVITY | lung cancer | prostate cancer | ONCOLOGY | HUMAN-MELANOMA CELLS | SERINE-PROTEASE | INDUCED DEATH | INHIBITOR | DERIVATIVES | Neoplasms - metabolism | Lung Neoplasms - drug therapy | Prostatic Neoplasms - metabolism | Triterpenes - pharmacology | Apoptosis - drug effects | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Male | Uterine Cervical Neoplasms - pathology | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Uterine Cervical Neoplasms - metabolism | Colorectal Neoplasms - drug therapy | Female | Colorectal Neoplasms - metabolism | Prostatic Neoplasms - drug therapy | Cell Survival - drug effects | Prostatic Neoplasms - pathology | Jurkat Cells | Cells, Cultured | Uterine Cervical Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Blotting, Western | Neoplasms - drug therapy | Poly(ADP-ribose) Polymerases - metabolism | Breast Neoplasms - pathology | Cell Line, Tumor | Antineoplastic Agents, Phytogenic - pharmacology | Colorectal Neoplasms - pathology | Neoplasms - pathology | Cancer
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 12/2015, Volume 39, Issue 12, pp. 1708 - 1718
In 2012, the College of American Pathologists and American Society for Colposcopy and Cervical Pathology published the “LAST... 
p16ink4 | intraepithelial neoplasia | VIN 2 | VAIN 2 | CIN 2 | Lower Anogenital Squamous Terminology (LAST) project | AIN 2 | CANCER PRECURSORS | SURGERY | P16(INK4A) IMMUNOHISTOCHEMISTRY | BIOPSY SPECIMENS | PATHOLOGY | NATURAL-HISTORY | CERVICAL INTRAEPITHELIAL NEOPLASIA | SITU HYBRIDIZATION | UTERINE CERVIX | IMPROVES INTEROBSERVER AGREEMENT | HIGH-RISK | HUMAN-PAPILLOMAVIRUS INFECTION | Immunohistochemistry | Predictive Value of Tests | Cervical Intraepithelial Neoplasia - pathology | Squamous Intraepithelial Lesions of the Cervix - therapy | Squamous Intraepithelial Lesions of the Cervix - pathology | Humans | Middle Aged | Squamous Intraepithelial Lesions of the Cervix - metabolism | Anus Neoplasms - virology | Male | Uterine Cervical Neoplasms - pathology | Young Adult | Vulvar Neoplasms - pathology | Vulvar Neoplasms - therapy | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Neoplasm Grading | Cervical Intraepithelial Neoplasia - therapy | Anus Neoplasms - therapy | Adult | Anus Neoplasms - chemistry | Female | Papillomavirus Infections - virology | Vaginal Neoplasms - therapy | Vaginal Neoplasms - chemistry | Uterine Cervical Neoplasms - therapy | Reproducibility of Results | Squamous Intraepithelial Lesions of the Cervix - virology | Biomarkers, Tumor - analysis | Cervical Intraepithelial Neoplasia - chemistry | Vaginal Neoplasms - pathology | Vulvar Neoplasms - virology | Anus Neoplasms - pathology | Vaginal Neoplasms - virology | Cervical Intraepithelial Neoplasia - virology | Biopsy | Uterine Cervical Neoplasms - virology | Aged | Uterine Cervical Neoplasms - chemistry | Observer Variation | Vulvar Neoplasms - chemistry
Journal Article
Best Practice & Research: Clinical Obstetrics & Gynaecology, ISSN 1521-6934, 2015, Volume 29, Issue 4, pp. 528 - 540
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2012, Volume 18, Issue 9, pp. 2558 - 2568
Journal Article
Acta oncologica, ISSN 1651-226X, 2014, Volume 53, Issue 9, pp. 1135 - 1142
... and LRIG3, have prognostic value in diverse types of cancer, including breast cancer [1,2], uterine cervical cancer [3-5], head-and-neck cancer [6-8], glioma [9,10... 
BREAST-CANCER | GROWTH-FACTOR RECEPTOR | RECEPTOR TYROSINE KINASES | ONCOLOGY | IMMUNOHISTOCHEMICAL ANALYSIS | LEUCINE-RICH REPEATS | SQUAMOUS-CELL CARCINOMA | TUMOR-SUPPRESSOR GENE | NEGATIVE REGULATOR LRIG1 | HUMAN-PAPILLOMAVIRUS STATUS | PATIENT SURVIVAL | Neoplasms - metabolism | Nasopharyngeal Neoplasms - genetics | Up-Regulation | Nasopharyngeal Neoplasms - metabolism | Prognosis | Membrane Glycoproteins - metabolism | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Male | Neoplasm Proteins - metabolism | RNA, Messenger - metabolism | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Glioma - metabolism | Glioma - genetics | Carcinoma, Squamous Cell - mortality | Neoplasms - genetics | Uterine Cervical Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Female | Membrane Proteins - metabolism | Neoplasm Proteins - genetics | Genes, Tumor Suppressor | Lung Neoplasms - genetics | Gene Expression | Glioma - mortality | Carcinoma, Non-Small-Cell Lung - genetics | Membrane Proteins - genetics | Down-Regulation | Carcinoma, Non-Small-Cell Lung - metabolism | Neoplasm Recurrence, Local | Neoplasms - mortality | Uterine Cervical Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - mortality | Membrane Glycoproteins - genetics | Animals | Breast Neoplasms - genetics | Head and Neck Neoplasms - genetics | Biomarkers, Tumor - genetics | Mice | Review
Journal Article
by Burk, Robert D and Chen, Zigui and Saller, Charles and Tarvin, Katherine and Carvalho, Andre L and Scapulatempo-Neto, Cristovam and Silveira, Henrique C and Fregnani, José H and Creighton, Chad J and Anderson, Matthew L and Castro, Patricia and Wang, Sophia S and Yau, Christina and Benz, Christopher and Gordon Robertson, A and Mungall, Karen and Lim, Lynette and Bowlby, Reanne and Sadeghi, Sara and Brooks, Denise and Sipahimalani, Payal and Mar, Richard and Ally, Adrian and Clarke, Amanda and Mungall, Andrew J and Tam, Angela and Lee, Darlene and Chuah, Eric and Schein, Jacqueline E and Tse, Kane and Kasaian, Katayoon and Ma, Yussanne and Marra, Marco A and Mayo, Michael and Balasundaram, Miruna and Thiessen, Nina and Dhalla, Noreen and Carlsen, Rebecca and Moore, Richard A and Holt, Robert A and Jones, Steven J. M and Wong, Tina and Pantazi, Angeliki and Parfenov, Michael and Kucherlapati, Raju and Hadjipanayis, Angela and Seidman, Jonathan and Kucherlapati, Melanie and Ren, Xiaojia and Xu, Andrew W and Yang, Lixing and Park, Peter J and Lee, Semin and Rabeno, Brenda and Huelsenbeck-Dill, Lori and Borowsky, Mark and Cadungog, Mark and Iacocca, Mary and Petrelli, Nicholas and Swanson, Patricia and Ojesina, Akinyemi I and Ojesina, Akinyemi I and Ojesina, Akinyemi I and Le, Xuan and Sandusky, George and Adebamowo, Sally N and Akeredolu, Teniola and Adebamowo, Clement and Reynolds, Sheila M and Shmulevich, Ilya and Shelton, Candace and Crain, Daniel and Mallery, David and Curley, Erin and Gardner, Johanna and Penny, Robert and Morris, Scott and Shelton, Troy and Liu, Jia and Lolla, Laxmi and Chudamani, Sudha and Wu, Ye and Birrer, Michael and McLellan, Michael D and Bailey, Matthew H and Miller, Christopher A and Wyczalkowski, Matthew A and Fulton, Robert S and Fronick, Catrina C and Lu, Charles and Mardis, Elaine R and Appelbaum, Elizabeth L and Schmidt, Heather K and Fulton, Lucinda A and Cordes, Matthew G and Li, Tiandao and Ding, Li and Wilson, Richard K and Rader, Janet S and Behmaram, Behnaz and ... and The Cancer Genome Atlas Research Network and Canc Genome Atlas Res Network and Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University and Research Institute at Nationwide Children's Hospital and University of Alabama at Birmingham and McDonnell Genome Institute at Washington University and Washington University in St Louis and University of Wisconsin School of Medicine &Public Health and National Hospital, Abuja, Nigeria and Baylor College of Medicine and Barretos Cancer Hospital and Indiana University School of Medicine and Ontario Tumour Bank, The Ottawa Hospital and Massachusetts General Hospital and University of New Mexico Health Sciences Center and National Institute on Deafness &Other Communication Disorders and University of North Carolina at Chapel Hill and Buck Institute for Research on Aging and Cancer Genome Atlas Research Network and Medical College of Wisconsin and University of Abuja Teaching Hospital and University of Oklahoma Health Sciences Center and Institute of Human Virology and St Joseph's Candler Health System and University of Pittsburgh and University of Texas MD Anderson Cancer Center and National Cancer Institute and Montefiore Medical Center and University of Southern California and Institute for Systems Biology and University of Washington and Analytical Biological Services and Harvard Medical School and National Human Genome Research Institute and Memorial Sloan Kettering Cancer Center and Medical University of South Carolina and Ontario Tumour Bank, London Health Sciences Centre and SRA International and University of Kansas Medical Center and University of Lausanne and ILSbio, LLC and University of Bergen and University of California, Irvine and Canada's Michael Smith Genome Sciences Centre and International Genomics Consortium and Oregon Health &Science University and NantOmics and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and University of São Paulo, Ribeir ão Preto Medical School and HudsonAlpha Institute for Biotechnology and Albert Einstein College of Medicine and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center and National Institute of Environmental Health Sciences and Van Andel Research Institute and Ontario Tumour Bank, Ontario Institute for Cancer Research and University of California Santa Cruz and Beckman Research Institute of City of Hope and Leidos Biomedical and Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services
Nature (London), ISSN 1476-4687, 2017, Volume 543, Issue 7645, pp. 378 - 384
Cervical cancer remains one of the leading causes of cancer-related deaths worldwide... 
EPITHELIAL-MESENCHYMAL-TRANSITION | TRANSCRIPTION FACTORS | BREAST-CANCER | ACCURATE | DNA METHYLATION | QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | 14-3-3-SIGMA | RESISTANCE | EXPRESSION | SIGNATURE | Receptors, Transforming Growth Factor beta - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Carcinoma, Squamous Cell - genetics | Genomics | Humans | APOBEC-1 Deaminase - genetics | Phosphatidylinositol 3-Kinases - metabolism | Molecular Targeted Therapy | Caspase 8 - genetics | Mitogen-Activated Protein Kinase Kinases - metabolism | Human papillomavirus 16 - isolation & purification | Receptor, Transforming Growth Factor-beta Type II | Female | Adenocarcinoma - genetics | Nuclear Proteins - genetics | Protein-Serine-Threonine Kinases - metabolism | PTEN Phosphohydrolase - genetics | Signal Transduction | Programmed Cell Death 1 Ligand 2 Protein - genetics | Protein-Serine-Threonine Kinases - genetics | Uterine Cervical Neoplasms - drug therapy | RNA, Long Noncoding - genetics | Receptor, ErbB-3 - genetics | Transcription Factors - genetics | Uterine Cervical Neoplasms - genetics | Virus Integration | B7-H1 Antigen - genetics | Receptors, Transforming Growth Factor beta - metabolism | HLA-A Antigens - genetics | Proteomics | Mutation | Keratins - genetics | Human papillomavirus 16 - genetics | Uterine Cervical Neoplasms - classification | Causes of | Care and treatment | Genetic aspects | Gene mutations | Health aspects | Cervical cancer | Human papillomavirus | Gynecology | Molecular biology | Cancer therapies | Tumors | Index Medicus
Journal Article
Journal Article